More on IPXL

- Summary
- Chart
- Profile
- Historical


- Earnings (-2.9% Growth)
- Ratings (3.5 Score)
- Holders
- FDA Archive


Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (8/9/16)


- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks

IPXL Balance Sheet

Click line-items for a historical chart and %
Current assets:
Cash and cash equivalents 412.18M
Short-term investments
Accounts receivable, net 214.45M
Inventory, net 133.56M
Deferred product manufacturing costs
Deferred income taxes
Prepaid expenses and other current assets 22.19M
Total current assets 782.37M
Property, plant and equipment, net 219.4M
Deferred product manufacturing costs
Deferred income taxes, net 284K
Other assets 79.11M
Goodwill 208.4M
Total assets 1.89B
Current liabilities:
Accounts payable 50.72M
Accrued expenses 213.11M
Accrued income taxes payable
Accrued profit sharing and royalty expenses 38.71M
Deferred revenue
Total current liabilities 302.55M
Deferred revenue
Other liabilities 36.99M
Total liabilities 816.87M
Commitments and contingencies (Note 8) 0
Stockholders' equity:
Preferred Stock, $ 0.01 par value, 2,000,000 shares authorized, 0 shares outstanding at June 30, 2011 and December 31, 2010 0
Common stock, $ 0.01 par value, 90,000,000 shares authorized and 65,872,062 and 64,721,041 shares issued at June 30, 2011 and December 31, 2010, respectively 733K
Additional paid-in capital 518.46M
Treasury stock-243,729 shares -2.16M
Accumulated other comprehensive income -7.42M
Retained earnings 559.82M
Stockholders' Equity Attributable to Parent, Total
Noncontrolling interest
Total stockholders' equity 1.07B
Total liabilities and stockholders' equity 1.89B